SE9302855D0 - Method and means for producing plasmaproteinase inhibitor binding proteins - Google Patents

Method and means for producing plasmaproteinase inhibitor binding proteins

Info

Publication number
SE9302855D0
SE9302855D0 SE9302855A SE9302855A SE9302855D0 SE 9302855 D0 SE9302855 D0 SE 9302855D0 SE 9302855 A SE9302855 A SE 9302855A SE 9302855 A SE9302855 A SE 9302855A SE 9302855 D0 SE9302855 D0 SE 9302855D0
Authority
SE
Sweden
Prior art keywords
pct
binding proteins
proteinase inhibitor
inhibitor binding
producing plasma
Prior art date
Application number
SE9302855A
Other languages
English (en)
Swedish (sv)
Inventor
Martin Lindberg
Original Assignee
Martin Lindberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Martin Lindberg filed Critical Martin Lindberg
Priority to SE9302855A priority Critical patent/SE9302855D0/xx
Publication of SE9302855D0 publication Critical patent/SE9302855D0/xx
Priority to DE69425149T priority patent/DE69425149T2/de
Priority to CA002176230A priority patent/CA2176230A1/en
Priority to US08/669,408 priority patent/US6100055A/en
Priority to ES94926448T priority patent/ES2149884T3/es
Priority to EP94926448A priority patent/EP0724596B1/de
Priority to AU76281/94A priority patent/AU7628194A/en
Priority to AT94926448T priority patent/ATE194360T1/de
Priority to PCT/SE1994/000826 priority patent/WO1995007296A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
SE9302855A 1993-09-06 1993-09-06 Method and means for producing plasmaproteinase inhibitor binding proteins SE9302855D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9302855A SE9302855D0 (sv) 1993-09-06 1993-09-06 Method and means for producing plasmaproteinase inhibitor binding proteins
DE69425149T DE69425149T2 (de) 1993-09-06 1994-09-06 Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen
CA002176230A CA2176230A1 (en) 1993-09-06 1994-09-06 Method and means for producing plasmaproteinase inhibitor-binding proteins
US08/669,408 US6100055A (en) 1993-09-06 1994-09-06 DNA encoding fα-2m-binding protein and protein encoded thereby
ES94926448T ES2149884T3 (es) 1993-09-06 1994-09-06 Metodo y medios para producir proteinas que se fijan a inhibidores de proteinasas de plasma.
EP94926448A EP0724596B1 (de) 1993-09-06 1994-09-06 Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen
AU76281/94A AU7628194A (en) 1993-09-06 1994-09-06 Method and means for producing plasmaproteinase inhibitor-binding proteins
AT94926448T ATE194360T1 (de) 1993-09-06 1994-09-06 Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen
PCT/SE1994/000826 WO1995007296A1 (en) 1993-09-06 1994-09-06 Method and means for producing plasmaproteinase inhibitor-binding proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9302855A SE9302855D0 (sv) 1993-09-06 1993-09-06 Method and means for producing plasmaproteinase inhibitor binding proteins

Publications (1)

Publication Number Publication Date
SE9302855D0 true SE9302855D0 (sv) 1993-09-06

Family

ID=20390977

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9302855A SE9302855D0 (sv) 1993-09-06 1993-09-06 Method and means for producing plasmaproteinase inhibitor binding proteins

Country Status (9)

Country Link
US (1) US6100055A (de)
EP (1) EP0724596B1 (de)
AT (1) ATE194360T1 (de)
AU (1) AU7628194A (de)
CA (1) CA2176230A1 (de)
DE (1) DE69425149T2 (de)
ES (1) ES2149884T3 (de)
SE (1) SE9302855D0 (de)
WO (1) WO1995007296A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9823975D0 (en) * 1998-11-02 1998-12-30 Actinova Ltd Protein
ATE357248T1 (de) * 2000-06-12 2007-04-15 Univ Saskatchewan Milchvieh immunisierung mit mig protein
IL154284A0 (en) * 2000-09-25 2003-09-17 Nestle Sa Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
US8404245B2 (en) 2002-10-11 2013-03-26 Intervacc Ab Immunization of non-human mammals against Streptococcus equi
US20110020403A1 (en) 2007-12-13 2011-01-27 Bengt Guss immunizing composition
WO2011149419A1 (en) 2010-05-26 2011-12-01 Intervacc Ab Vaccine against streptococcal infections based on recombinant proteins
EP3604341A4 (de) * 2017-03-31 2020-12-09 Kaneka Corporation Affinitätsdissoziationsmatrix für immunglobulin-reinigungszwecke
RU2758604C2 (ru) * 2019-12-10 2021-11-01 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Рекомбинантный белок GM, обладающий способностью связывать α2-макроглобулин и его применение в качестве лиганда в аффинной хроматографии для выделения α2-макроглобулина из сыворотки крови человека

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins

Also Published As

Publication number Publication date
ES2149884T3 (es) 2000-11-16
WO1995007296A1 (en) 1995-03-16
ATE194360T1 (de) 2000-07-15
EP0724596A1 (de) 1996-08-07
CA2176230A1 (en) 1995-03-16
US6100055A (en) 2000-08-08
EP0724596B1 (de) 2000-07-05
DE69425149D1 (de) 2000-08-10
AU7628194A (en) 1995-03-27
DE69425149T2 (de) 2001-03-15

Similar Documents

Publication Publication Date Title
PL319782A1 (en) Inhibitors of serinic proteases and anticoagulative protecins extracted from nematodes
TR199802133T2 (xx) Pirazinon trombin inhibit�rleri.
AU7928194A (en) Tissue inhibitor metalloproteinase type three (timp-3)
AU8131294A (en) Human kunitz-type protease inhibitors
BG102612A (en) Complementary adenoviral vector systems and cellular lines
EA199700087A1 (ru) Способ ингибирования катепсина к
DE3587875D1 (de) Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
SE9302855D0 (sv) Method and means for producing plasmaproteinase inhibitor binding proteins
GR3036782T3 (en) Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding.
IL122606A0 (en) (S)-hydroxy-nitrile-lyase
AU3166295A (en) Imidazopyridine-azolidinones
ATE226591T1 (de) Oligopeptide hergeleitet von fragmenten des c- reaktiven proteins
PL318812A1 (en) Method of identifying compounds suitable for treating auto-aggressive diseases
AU1388295A (en) Use of at least one terpenic carbide and/or a derivative thereof as an additive to a herbicide slurry or coformulant of a herbicide composition
DE69434072D1 (de) Regulierende nukleinsaeuresequenzen und verwendungen
ATE423211T1 (de) Produktion von proteinen, dafür kodierende plasmide und organismen, die solche plasmide enthalten
AU8107094A (en) Endothelin-converting enzyme
SE9302856D0 (sv) Method and means for producing a plasmapeotein-binding protein
ATE439442T1 (de) An der bildung einer in exon 5 defekten spleissvariante des presenilin-2-gens beteiligte nukleinsäure
DE59611353D1 (de) Transketolase-verwandtes protein
DK0711450T3 (da) Plenar-transducer.